These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35388427)

  • 1. NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children.
    Schmitz A; Wood KE; Badheka A; Burghardt E; Wendt L; Sharathkumar A; Koestner B
    Hosp Pediatr; 2022 Jul; 12(7):e261-e265. PubMed ID: 35388427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M; Nandi A; Banerjee P; Gupta P; Sarkar SD; Basu S; Pal P
    Int J Rheum Dis; 2022 Jan; 25(1):27-31. PubMed ID: 34750969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP course during MIS-C post-COVID-19: an observational study.
    Bichali S; Ouldali N; Godart F; Maboudou P; Houeijeh A; Leteurtre S
    Eur J Pediatr; 2024 Apr; 183(4):1667-1674. PubMed ID: 38206397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY; Han MY; Cha SH; Jeon YB
    Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
    Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D
    Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
    Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
    Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
    N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem inflammatory syndrome in children: Inputs of BNP, NT-proBNP and Galectin-3.
    Raynor A; Vallée C; Belkarfa AL; Lunte K; Laney M; Belhadjer Z; Vicca S; Boutten A; Bonnet D; Nivet-Antoine V
    Clin Chim Acta; 2022 Apr; 529():109-113. PubMed ID: 35183528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide levels in children: comparison in cardiac and non-cardiac diseases.
    Kim HS; Choi HJ
    Cardiol Young; 2020 Apr; 30(4):500-504. PubMed ID: 32102709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Multisystem Inflammatory Syndrome in Children.
    McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
    N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea.
    Goldbart AD; Levitas A; Greenberg-Dotan S; Ben Shimol S; Broides A; Puterman M; Tal A
    Chest; 2010 Sep; 138(3):528-35. PubMed ID: 20558551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death After Reperfusion Therapy in Acute Ischemic Stroke Patients.
    Zhang X; Yan S; Zhong W; Yu Y; Lou M
    Stroke; 2021 Jan; 52(2):537-542. PubMed ID: 33406870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.
    Zhao Y; Patel J; Huang Y; Yin L; Tang L
    Am J Emerg Med; 2021 Nov; 49():62-70. PubMed ID: 34082189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
    Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
    Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
    BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.